<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.1//EN" "http://www.w3.org/TR/xhtml11/DTD/xhtml11.dtd">




<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
<head>
  <title>V3/substanceAdminSubstitution/v3-substanceAdminSubstitution.json - FHIR v0.80</title>

  
  <meta name="viewport" content="width=device-width, initial-scale=1.0"/>
  <meta name="author" content="http://hl7.org/fhir"/>

  <link href="../../fhir.css" rel="stylesheet"/>


  <!-- Bootstrap core CSS -->
  <link href="../.././dist/css/bootstrap.css" rel="stylesheet"/>
  <link href="../.././assets/css/bootstrap-fhir.css" rel="stylesheet"/>

  <!-- Project extras -->
  <link href="../.././assets/css/project.css" rel="stylesheet"/>
  <link href="../.././assets/css/pygments-manni.css" rel="stylesheet"/>

  <!-- HTML5 shim and Respond.js IE8 support of HTML5 elements and media queries -->
  <!--[if lt IE 9]>
  <script src="../.././assets/js/html5shiv.js"></script>
  <script src="../.././assets/js/respond.min.js"></script>
  <![endif]-->

  <!-- Favicons -->
  <link rel="apple-touch-icon-precomposed" sizes="144x144" href="../.././assets/ico/apple-touch-icon-144-precomposed.png"/>
  <link rel="apple-touch-icon-precomposed" sizes="114x114" href="../.././assets/ico/apple-touch-icon-114-precomposed.png"/>
  <link rel="apple-touch-icon-precomposed" sizes="72x72" href="../.././assets/ico/apple-touch-icon-72-precomposed.png"/>
  <link rel="apple-touch-icon-precomposed" href="../.././assets/ico/apple-touch-icon-57-precomposed.png"/>
  <link rel="shortcut icon" href="../.././assets/ico/favicon.png"/>

</head>
<body>
	<div id="segment-header" class="segment"><!-- segment-header -->	
		<div class="container"><!-- container -->
			<a id="logo" href="http://hl7.org/fhir"><img src="../.././assets/images/fhir-logo-www.png" alt="logo fhir"/> </a>
			<div id="hl7-status">
				<b>Nightly</b>
			</div>       	
			
			<div id="hl7-nav">
				 <a id="hl7-logo" href="http://www.hl7.org">
					<img src="../.././assets/images/hl7-logo.png" width="42" height="50" alt="visit the hl7 website"/>
				</a> 
			</div>       	
			<div id="hl7-search"> </div>
		</div>
		<div class="container"><!-- container -->
	</div></div><!-- /segment-header -->	


	<div id="segment-navbar" class="segment"><!-- segment-navbar -->
		<div id="stripe"> </div>
		<div class="container"><!-- container -->
 <!-- HEADER CONTENT -->
 	      		
 	      		      		
			<nav class="navbar navbar-inverse">
				<div class="container">
					<button data-target=".navbar-inverse-collapse" data-toggle="collapse" class="navbar-toggle" type="button">
						<span class="icon-bar"> </span>
						<span class="icon-bar"> </span>
						<span class="icon-bar"> </span>
					</button>
					<a href="../../index.html" class="navbar-brand hidden">FHIR</a>
					<div class="nav-collapse collapse navbar-inverse-collapse">
						<ul class="nav navbar-nav">
              <li><a href="../../index.html">Home</a></li>
              <li><a href="../../documentation.html">Documentation</a></li>
              <li><a href="../../implementation.html">Implementation</a></li>
              <li><a href="../../resourcelist.html">Resources</a></li>
              <li><a href="../../clinical.html">Clinical</a></li>
              <li><a href="../../administration.html">Administrative</a></li>
              <li><a href="../../infrastructure.html">Infrastructure</a></li>

						</ul>
					</div><!-- /.nav-collapse -->
				</div><!-- /.container -->
			</nav><!-- /.navbar -->
      		
				
<!-- /HEADER CONTENT -->				
		</div><!-- /container -->
	</div><!-- /segment-navbar -->
	

	<div id="segment-breadcrumb" class="segment"><!-- segment-breadcrumb -->
		<div class="container"><!-- container -->	
			<ul class="breadcrumb">
        <li><a href="../../index.html">Home</a></li>
        <li><a href="../../documentation.html">Documentation</a></li>        <li><a href="../../terminologies.html">Using Codes</a></li>        <li><a href="../../terminologies-v3.html">V3 Namespaces</a></li>        <li><a href="index.html">v3-substanceAdminSubstitution</a></li>        <li><b>Instance</b></li>        <!-- v3/substanceAdminSubstitution/v3-substanceAdminSubstitution.json.html / v3:cs:substanceAdminSubstitution -->

			</ul>	
		</div><!-- /container -->
	</div><!-- /segment-breadcrumb -->
	

	<div id="segment-content" class="segment"><!-- segment-content -->
	<div class="container"><!-- container -->
            <div class="row">
            	<div class="inner-wrapper">
<!-- CONTENT CONTENT -->


<div class="col-9">

<h1>V3/substanceAdminSubstitution/v3-substanceAdminSubstitution.json</h1>

<div class="example">
<p> Identifies what sort of change is permitted or has occurred between the therapy that was ordered and the therapy that was/will be provided.</p>
<pre class="json">
{
  &quot;resourceType&quot;: &quot;ValueSet&quot;,
  &quot;text&quot;: {
    &quot;status&quot;: &quot;generated&quot;,
    &quot;div&quot;: &quot;&lt;div&gt;&lt;p&gt;Release Date: 2013-12-07&lt;/p&gt;\r\n&lt;h2&gt;Description&lt;/h2&gt;\r\n&lt;p&gt;\n                  Identifies what sort of change is permitted or has occurred between the therapy that was ordered and the therapy that was/will be provided.&lt;br/&gt;\r\n\n               &lt;/p&gt;\r\n&lt;hr/&gt;\r\n&lt;table class=\&quot;grid\&quot;&gt;\r\n &lt;tr&gt;&lt;td&gt;&lt;b&gt;Level&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;Code&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;Display&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;Definition&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;\r\n &lt;tr&gt;&lt;td&gt;1&lt;/td&gt;&lt;td&gt;&lt;span style=\&quot;color: grey\&quot;&gt;&lt;i&gt;(_ActSubstanceAdminSubstitutionCode)&lt;/i&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;a name=\&quot;_ActSubstanceAdminSubstitutionCode\&quot;&gt;&amp;nbsp;&lt;/a&gt;&lt;/td&gt;&lt;td&gt;\n                        \n                           Description: Substitution occurred or is permitted with another product that may potentially have different ingredients, but having the same biological and therapeutic effects.&lt;br/&gt;\r\n\n                     &lt;/td&gt;&lt;/tr&gt;\r\n &lt;tr&gt;&lt;td&gt;2&lt;/td&gt;&lt;td&gt;&amp;nbsp;&amp;nbsp;E&lt;a name=\&quot;E\&quot;&gt; &lt;/a&gt;&lt;/td&gt;&lt;td&gt;equivalent&lt;/td&gt;&lt;td&gt;\n                        \n                           Description: Substitution occurred or is permitted with another bioequivalent and therapeutically equivalent product.&lt;br/&gt;\r\n\n                     &lt;/td&gt;&lt;/tr&gt;\r\n &lt;tr&gt;&lt;td&gt;3&lt;/td&gt;&lt;td&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;EC&lt;a name=\&quot;EC\&quot;&gt; &lt;/a&gt;&lt;/td&gt;&lt;td&gt;equivalent composition&lt;/td&gt;&lt;td&gt;\n                        \n                           Description: \n                        &lt;br/&gt;\r\n\n                        Substitution occurred or is permitted with another product that is a:&lt;br/&gt;\r\n\n                        \n                           pharmaceutical alternative containing the same active ingredient but is formulated with different salt, ester\n                           pharmaceutical equivalent that has the same active ingredient, strength, dosage form and route of administration\n                        \n                        \n                           Examples: \n                        &lt;br/&gt;\r\n\n                        \n                           \n                              Pharmaceutical alternative: Erythromycin Ethylsuccinate for Erythromycin Stearate\n                           \n                              Pharmaceutical equivalent: Lisonpril for Zestril\n                        \n                     &lt;/td&gt;&lt;/tr&gt;\r\n &lt;tr&gt;&lt;td&gt;4&lt;/td&gt;&lt;td&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;BC&lt;a name=\&quot;BC\&quot;&gt; &lt;/a&gt;&lt;/td&gt;&lt;td&gt;brand composition&lt;/td&gt;&lt;td&gt;\n                        \n                           Description: \n                        &lt;br/&gt;\r\n\n                        Substitution occurred or is permitted between equivalent Brands but not Generics&lt;br/&gt;\r\n\n                        \n                           Examples: \n                        &lt;br/&gt;\r\n\n                        \n                           Zestril  for Prinivil\n                           Coumadin for Jantoven\n                        \n                     &lt;/td&gt;&lt;/tr&gt;\r\n &lt;tr&gt;&lt;td&gt;4&lt;/td&gt;&lt;td&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;G&lt;a name=\&quot;G\&quot;&gt; &lt;/a&gt;&lt;/td&gt;&lt;td&gt;generic composition&lt;/td&gt;&lt;td&gt;\n                        \n                           Description: Substitution occurred or is permitted between equivalent Generics but not Brands&lt;br/&gt;\r\n\n                        \n                           Examples: \n                        &lt;br/&gt;\r\n\n                        \n                           Lisnopril (Lupin Corp) for Lisnopril (Wockhardt Corp)\n                        \n                     &lt;/td&gt;&lt;/tr&gt;\r\n &lt;tr&gt;&lt;td&gt;3&lt;/td&gt;&lt;td&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;TE&lt;a name=\&quot;TE\&quot;&gt; &lt;/a&gt;&lt;/td&gt;&lt;td&gt;therapeutic alternative&lt;/td&gt;&lt;td&gt;\n                        \n                           Description: Substitution occurred or is permitted with another product having the same therapeutic objective and safety profile.&lt;br/&gt;\r\n\n                        \n                           Examples: \n                        &lt;br/&gt;\r\n\n                        \n                           ranitidine for Tagamet\n                        \n                     &lt;/td&gt;&lt;/tr&gt;\r\n &lt;tr&gt;&lt;td&gt;4&lt;/td&gt;&lt;td&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;TB&lt;a name=\&quot;TB\&quot;&gt; &lt;/a&gt;&lt;/td&gt;&lt;td&gt;therapeutic brand&lt;/td&gt;&lt;td&gt;\n                        \n                           Description: Substitution occurred or is permitted between therapeutically equivalent Brands but not Generics&lt;br/&gt;\r\n&amp;gt;\n                           Examples: \n                        &lt;br/&gt;\r\n\n                        \n                           Zantac for Tagamet\n                        \n                     &lt;/td&gt;&lt;/tr&gt;\r\n &lt;tr&gt;&lt;td&gt;4&lt;/td&gt;&lt;td&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;TG&lt;a name=\&quot;TG\&quot;&gt; &lt;/a&gt;&lt;/td&gt;&lt;td&gt;therapeutic generic&lt;/td&gt;&lt;td&gt;\n                        \n                           Description: Substitution occurred or is permitted between therapeutically equivalent Generics but not Brands&lt;br/&gt;\r\n&amp;gt;\n                           Examples: \n                        &lt;br/&gt;\r\n\n                        \n                           Ranitidine  for cimetidine\n                        \n                     &lt;/td&gt;&lt;/tr&gt;\r\n &lt;tr&gt;&lt;td&gt;2&lt;/td&gt;&lt;td&gt;&amp;nbsp;&amp;nbsp;F&lt;a name=\&quot;F\&quot;&gt; &lt;/a&gt;&lt;/td&gt;&lt;td&gt;formulary&lt;/td&gt;&lt;td&gt;\n                        \n                           Description: This substitution was performed or is permitted based on formulary guidelines. &lt;br/&gt;\r\n\n                     &lt;/td&gt;&lt;/tr&gt;\r\n &lt;tr&gt;&lt;td&gt;2&lt;/td&gt;&lt;td&gt;&amp;nbsp;&amp;nbsp;N&lt;a name=\&quot;N\&quot;&gt; &lt;/a&gt;&lt;/td&gt;&lt;td&gt;none&lt;/td&gt;&lt;td&gt;\n                        No substitution occurred or is permitted.&lt;br/&gt;\r\n\n                     &lt;/td&gt;&lt;/tr&gt;\r\n&lt;/table&gt;\r\n&lt;/div&gt;&quot;
  },
  &quot;identifier&quot;: &quot;http://hl7.org/fhir/v3/vs/substanceAdminSubstitution&quot;,
  &quot;name&quot;: &quot;v3 Code System substanceAdminSubstitution&quot;,
  &quot;publisher&quot;: &quot;HL7, Inc&quot;,
  &quot;telecom&quot;: [
    {
      &quot;system&quot;: &quot;url&quot;,
      &quot;value&quot;: &quot;http://hl7.org&quot;
    }
  ],
  &quot;description&quot;: &quot; Identifies what sort of change is permitted or has occurred between the therapy that was ordered and the therapy that was/will be provided.&quot;,
  &quot;status&quot;: &quot;active&quot;,
  &quot;date&quot;: &quot;2013-12-07T00:00:00-00:00&quot;,
  &quot;define&quot;: {
    &quot;system&quot;: &quot;http://hl7.org/fhir/v3/substanceAdminSubstitution&quot;,
    &quot;caseSensitive&quot;: true,
    &quot;concept&quot;: [
      {
        &quot;code&quot;: &quot;_ActSubstanceAdminSubstitutionCode&quot;,
        &quot;abstract&quot;: true,
        &quot;display&quot;: &quot;ActSubstanceAdminSubstitutionCode&quot;,
        &quot;definition&quot;: &quot;Description: Substitution occurred or is permitted with another product that may potentially have different ingredients, but having the same biological and therapeutic effects.&quot;,
        &quot;concept&quot;: [
          {
            &quot;code&quot;: &quot;E&quot;,
            &quot;display&quot;: &quot;equivalent&quot;,
            &quot;definition&quot;: &quot;Description: Substitution occurred or is permitted with another bioequivalent and therapeutically equivalent product.&quot;,
            &quot;concept&quot;: [
              {
                &quot;code&quot;: &quot;EC&quot;,
                &quot;display&quot;: &quot;equivalent composition&quot;,
                &quot;definition&quot;: &quot;Description: \n                        \r\n\n                        Substitution occurred or is permitted with another product that is a:\r\n\n                        \n                           pharmaceutical alternative containing the same active ingredient but is formulated with different salt, ester\n                           pharmaceutical equivalent that has the same active ingredient, strength, dosage form and route of administration\n                        \n                        \n                           Examples: \n                        \r\n\n                        \n                           \n                              Pharmaceutical alternative: Erythromycin Ethylsuccinate for Erythromycin Stearate\n                           \n                              Pharmaceutical equivalent: Lisonpril for Zestril&quot;,
                &quot;concept&quot;: [
                  {
                    &quot;code&quot;: &quot;BC&quot;,
                    &quot;display&quot;: &quot;brand composition&quot;,
                    &quot;definition&quot;: &quot;Description: \n                        \r\n\n                        Substitution occurred or is permitted between equivalent Brands but not Generics\r\n\n                        \n                           Examples: \n                        \r\n\n                        \n                           Zestril  for Prinivil\n                           Coumadin for Jantoven&quot;
                  },
                  {
                    &quot;code&quot;: &quot;G&quot;,
                    &quot;display&quot;: &quot;generic composition&quot;,
                    &quot;definition&quot;: &quot;Description: Substitution occurred or is permitted between equivalent Generics but not Brands\r\n\n                        \n                           Examples: \n                        \r\n\n                        \n                           Lisnopril (Lupin Corp) for Lisnopril (Wockhardt Corp)&quot;
                  }
                ]
              },
              {
                &quot;code&quot;: &quot;TE&quot;,
                &quot;display&quot;: &quot;therapeutic alternative&quot;,
                &quot;definition&quot;: &quot;Description: Substitution occurred or is permitted with another product having the same therapeutic objective and safety profile.\r\n\n                        \n                           Examples: \n                        \r\n\n                        \n                           ranitidine for Tagamet&quot;,
                &quot;concept&quot;: [
                  {
                    &quot;code&quot;: &quot;TB&quot;,
                    &quot;display&quot;: &quot;therapeutic brand&quot;,
                    &quot;definition&quot;: &quot;Description: Substitution occurred or is permitted between therapeutically equivalent Brands but not Generics\r\n&gt;\n                           Examples: \n                        \r\n\n                        \n                           Zantac for Tagamet&quot;
                  },
                  {
                    &quot;code&quot;: &quot;TG&quot;,
                    &quot;display&quot;: &quot;therapeutic generic&quot;,
                    &quot;definition&quot;: &quot;Description: Substitution occurred or is permitted between therapeutically equivalent Generics but not Brands\r\n&gt;\n                           Examples: \n                        \r\n\n                        \n                           Ranitidine  for cimetidine&quot;
                  }
                ]
              }
            ]
          },
          {
            &quot;code&quot;: &quot;F&quot;,
            &quot;display&quot;: &quot;formulary&quot;,
            &quot;definition&quot;: &quot;Description: This substitution was performed or is permitted based on formulary guidelines.&quot;
          },
          {
            &quot;code&quot;: &quot;N&quot;,
            &quot;display&quot;: &quot;none&quot;,
            &quot;definition&quot;: &quot;No substitution occurred or is permitted.&quot;
          }
        ]
      }
    ]
  }
}
</pre>
</div>



</div>


				</div><!-- /inner-wrapper -->
            </div><!-- /row -->
        </div><!-- /container -->
        
    </div><!-- /segment-content -->


	<div id="segment-footer" class="segment"><!-- segment-footer -->
		<div class="container"><!-- container -->
			<div class="inner-wrapper">
				<p>
        © HL7.org 2011 - 2014. FHIR DSTU (v0.80-????) generated on Thu, Apr 3, 2014 04:15+0000. <!-- <a href="../../qa.html">QA Report</a> --> <!-- achive note -->
        <br/>
        <span style="color: #FFFF77">
        Links: <a href="../../dstu.html">What's a DSTU?</a> | <a href="../../history.html">Version History</a> | <a href="../../license.html">License</a> | <a href="http://gforge.hl7.org/gf/project/fhir/tracker/?action=TrackerItemAdd&amp;tracker_id=677">Propose a change</a>
        </span>
        </p>
			</div><!-- /inner-wrapper -->
		</div><!-- /container -->
	</div><!-- /segment-footer -->
<!-- disqus thread -->
<!--disqus-->
<!-- end disqus -->        
	
	<div id="segment-post-footer" class="segment hidden"><!-- segment-post-footer -->
		<div class="container"><!-- container -->
		</div><!-- /container -->
	</div><!-- /segment-post-footer -->
    
    <!-- JS and analytics only. -->
    <!-- Bootstrap core JavaScript
================================================== -->
<!-- Placed at the end of the document so the pages load faster -->
<script src="../.././assets/js/jquery.js"> </script>   <!-- note keep space here, otherwise it will be transformed to empty tag -> fails -->
<script src="../.././dist/js/bootstrap.min.js"> </script>
<script src="../.././assets/js/respond.min.js"> </script>

<script src="../.././assets/js/fhir.js"> </script>

<!-- Analytics Below
================================================== -->

    
</body>
</html>
